APA (7th ed.) Citation

K, O., FA, T., R, E., R, O., SM, O., IK, D., . . . Y, Y. (2022). Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022. MMWR. Morbidity and mortality weekly report, 71(37), 1190. https://doi.org/10.15585/mmwr.mm7137e1

Chicago Style (17th ed.) Citation

K, O'Laughlin, et al. "Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022." MMWR. Morbidity and Mortality Weekly Report 71, no. 37 (2022): 1190. https://doi.org/10.15585/mmwr.mm7137e1.

MLA (9th ed.) Citation

K, O'Laughlin, et al. "Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022." MMWR. Morbidity and Mortality Weekly Report, vol. 71, no. 37, 2022, p. 1190, https://doi.org/10.15585/mmwr.mm7137e1.